Global Retirement Partners’s 10x Genomics TXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$38.9K Buy
+1,014
New +$26.6K ﹤0.01% 2682
2025
Q4
$5.5K Buy
337
+292
+649% +$4.41K ﹤0.01% 3407
2025
Q3
$526 Hold
45
– – ﹤0.01% 3638
2025
Q2
$521 Buy
+45
New +$410 ﹤0.01% 3573
2024
Q4
$57 Hold
4
– – ﹤0.01% 3579
2024
Q3
$90 Sell
4
-1
-20% -$21 ﹤0.01% 3413
2024
Q2
$97 Sell
5
-17
-77% -$445 ﹤0.01% 3458
2024
Q1
$826 Sell
22
-150
-87% -$6.59K ﹤0.01% 3023
2023
Q4
$7.66K Sell
172
-97
-36% -$4.22K ﹤0.01% 2168
2023
Q3
$10.7K Buy
269
+12
+5% +$624 ﹤0.01% 1927
2023
Q2
$14.4K Buy
257
+240
+1,412% +$13K ﹤0.01% 1821
2023
Q1
$918 Buy
17
+5
+42% +$233 ﹤0.01% 2760
2022
Q4
$437 Hold
12
– – ﹤0.01% 2791
2022
Q3
$0 Sell
12
-7
-37% -$267 ﹤0.01% 2986
2022
Q2
$1K Buy
19
+15
+375% +$778 ﹤0.01% 2580
2022
Q1
$0 Buy
+4
New +$350 ﹤0.01% 2786

Other funds holding TXG

Global Retirement Partners's TXG Position: Q2 2026 in Review

Global Retirement Partners opened a new position in 10x Genomics (TXG) in Q2 2026: 1,014 shares worth $38.9K. The stake represents ﹤0.01% of the portfolio and ranks #2682 among its holdings. This is a return to the name: Global Retirement Partners previously reported a position in TXG as recently as Q4 2025.

Global Retirement Partners first reported a position in TXG in Q1 2022 and has held it in 16 quarters since. 393 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • Global Retirement Partners held 1,014 shares of 10x Genomics worth $38.9K as of Q2 2026.
  • 10x Genomics was a new Global Retirement Partners position in Q2 2026.
  • 10x Genomics made up ﹤0.01% of Global Retirement Partners's portfolio in Q2 2026, its #2682 holding.
  • Global Retirement Partners first reported a position in 10x Genomics in Q1 2022 and has held it in 16 quarters since.
  • 393 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Global Retirement Partners's 13F filing for Q2 2026, filed 6 Aug 2026.